Association between the Growth Hormone Receptor Exon 3 Polymorphism and Metabolic Factors in Korean Patients with Acromegaly
Hye Yoon Park (Park HY), In Ryang Hwang (Hwang IR), Jung Bum Seo (Seo JB), Su Won Kim (Kim SW), Hyun Ae Seo (Seo HA), In Kyu Lee (Lee IK), Jung Guk Kim (Kim JG)
Endocrinol Metab. 2015;30(3):312-317.   Published online 2015 Jan 5     DOI:
Citations to this article as recorded by Crossref logo
Exon 3-deleted growth hormone receptor isoform is not related to worse bone mineral density or microarchitecture or to increased fracture risk in acromegaly
J. Pontes, M. Madeira, C. H. A. Lima, L. L. Ogino, F. de Paula Paranhos Neto, L. M. C. de Mendonça, M. L. F. Farias, L. Kasuki, M. R. Gadelha
Journal of Endocrinological Investigation.2020; 43(2): 163.     CrossRef
MECHANISMS IN ENDOCRINOLOGY: Lessons from growth hormone receptor gene-disrupted mice: are there benefits of endocrine defects?
Reetobrata Basu, Yanrong Qian, John J Kopchick
European Journal of Endocrinology.2018; 178(5): R155.     CrossRef
MECHANISMS IN ENDOCRINOLOGY: Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism
Cesar L Boguszewski, Edna J L Barbosa, Per-Arne Svensson, Gudmundur Johannsson, Camilla A M Glad
European Journal of Endocrinology.2017; 177(6): R309.     CrossRef